NHS National Generic Pharmaceuticals Interim 2

NHS England Published 16 Feb 2021 Contracts Finder

key details

Value	£18,767,757
Status	cancelled
Category (CPV)	33690000
Deadline	5 Oct 2020
Contract start	1 Feb 2021
Contract end	28 Feb 2022
Procedure	open
SME suitable	Yes
OCID	ocds-b5fd17-fb12a8e2-17d3-49d5-bb3b-a982582d6e51

Awards (51)

This procurement was awarded to 51 suppliers. Values shown are per-award; the notice total is £18,767,757.

Supplier	Value	Date	Status
Abbvie Ltd shared	£12,327,097	21 Dec 2020	active
Accord-UK Ltd shared	£12,327,097	21 Dec 2020	active
Altan Pharma Ltd shared	£12,327,097	21 Dec 2020	active
Amarox Limited shared	£12,327,097	21 Dec 2020	active
Aspire Pharma Limited shared	£12,327,097	21 Dec 2020	active
Aventis Pharma ltd t/a Sanofi shared	£12,327,097	21 Dec 2020	active
Baxter Healthcare Ltd shared	£12,327,097	21 Dec 2020	active
Bristol Laboratories Limited shared	£12,327,097	21 Dec 2020	active
Brown & Burk UK Ltd shared	£12,327,097	21 Dec 2020	active
Cipla (EU) Ltd shared	£12,327,097	21 Dec 2020	active
Consilient Health Ltd shared	£12,327,097	21 Dec 2020	active
Crescent Pharma Ltd shared	£12,327,097	21 Dec 2020	active
CST Pharma Limited shared	£12,327,097	21 Dec 2020	active
Drugsrus Ltd shared	£12,327,097	21 Dec 2020	active
Essential-Healthcare Ltd shared	£12,327,097	21 Dec 2020	active
Focus Pharmaceuticals Ltd shared	£12,327,097	21 Dec 2020	active
Fresenius Kabi Limited shared	£12,327,097	21 Dec 2020	active
GlaxoSmithKline UK Limited shared	£12,327,097	21 Dec 2020	active
Glenmark Pharmaceuticals Europe Limited shared	£12,327,097	21 Dec 2020	active
Healthcare Pharma Ltd shared	£12,327,097	21 Dec 2020	active
HFA Healthcare Products Limited shared	£12,327,097	21 Dec 2020	active
Kent Pharma Ltd shared	£12,327,097	21 Dec 2020	active
Laboratorio Reig Jofre SA shared	£12,327,097	21 Dec 2020	active
Lexon UK Ltd shared	£12,327,097	21 Dec 2020	active
Macleods Pharma UK Limited shared	£12,327,097	21 Dec 2020	active
Manx Healthcare Ltd shared	£12,327,097	21 Dec 2020	active
Martindale Pharma shared	£12,327,097	21 Dec 2020	active
medac Pharma LLP shared	£12,327,097	21 Dec 2020	active
Medley Pharma Ltd shared	£12,327,097	21 Dec 2020	active
Medreich PLC shared	£12,327,097	21 Dec 2020	active
Mercury Pharmaceuticals Limited shared	£12,327,097	21 Dec 2020	active
Milpharm Ltd/aurobinbdo shared	£12,327,097	21 Dec 2020	active
Morningside Pharmaeuticals shared	£12,327,097	21 Dec 2020	active
Mylan shared	£12,327,097	21 Dec 2020	active
Necessity Supplies Limited shared	£12,327,097	21 Dec 2020	active
Panpharma UK Limited shared	£12,327,097	21 Dec 2020	active
Pfizer Ltd shared	£12,327,097	21 Dec 2020	active
QDEM PHARMACEUTICALS LIMITED shared	£12,327,097	21 Dec 2020	active
Ranbaxy UK shared	£12,327,097	21 Dec 2020	active
Rivopharm UK Ltd shared	£12,327,097	21 Dec 2020	active
Sandoz Ltd shared	£12,327,097	21 Dec 2020	active
Sciecure Pharma Limited shared	£12,327,097	21 Dec 2020	active
Selective Supplies Ltd. shared	£12,327,097	21 Dec 2020	active
Syri Limited (T/A Thame Laboratories) shared	£12,327,097	21 Dec 2020	active
Teva UK Limited shared	£12,327,097	21 Dec 2020	active
Thornton and Ross Ltd shared	£12,327,097	21 Dec 2020	active
Tillomed Laboratories ltd shared	£12,327,097	21 Dec 2020	active
UpJohn Limited UK shared	£12,327,097	21 Dec 2020	active
Waymade PLC shared	£12,327,097	21 Dec 2020	active
Wockhardt UK Limited shared	£12,327,097	21 Dec 2020	active
Zentiva Pharma UK Ltd shared	£12,327,097	21 Dec 2020	active

description

NHS National Generic Pharmaceuticals Interim 2 2020

Offer reference number: CM/PHG/20/5619

Period of framework agreement: 12 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months. The total maximum duration of the framework agreement to be no more than 48 months Potential periods of call-offs under the framework agreement:

Hospital only products - All regions:	01/02/2021 to 31/01/2022
Orals (plus non-parenterals) - All regions:	01/03/2021 to 28/02/2022

documents

https://www.contractsfinder.service.gov.uk/Notice/5cbccead-509c-48ed-9384-016dd54ef316 , tenderNotice

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

Published	Type	Regime	Notice
16 Feb 2021	Tender cancelled (tenderCancellation)	·	5cbccead-509c-48ed-9384-016dd54ef316-413581
16 Feb 2021	Award (award)	·	c915f888-00fd-4d17-a50e-f9891d77f9fa-413594

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

Labs Consumables ePunchout 3 · UNIVERSITY OF SOUTHAMPTON · £1,500,000
Supply of reagents · NEWCASTLE UNIVERSITY · £177,420
Supply of reagents · NEWCASTLE UNIVERSITY · £37,829
Supply of reagents · NEWCASTLE UNIVERSITY · £36,485
Supply of Antibodies · NEWCASTLE UNIVERSITY · £23,108
Suplly of Reagents · NEWCASTLE UNIVERSITY · £23,212
Controlled drugs · London Ambulance Service NHS Trust · £154,225
IonOptix cardiomyocyte fluo-3 calcium and contractility acquisition system. · UNIVERSITY OF NOTTINGHAM (THE) · £67,737

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.